Regulatory Q&A Forum

For a connected medical device, such as a continuous glucose monitoring system or a wireless cardiac monitor, how should a manufacturer structure the cybersecurity documentation within a premarket sub...

For non-EU operators, particularly those in regulated sectors like medical devices who are familiar with appointing an EU Authorized Representative (AR) under the MDR, how should the selection process...

While specific fees for appointing an EU representative for the Carbon Border Adjustment Mechanism (CBAM) vary, what are the primary factors that influence the overall cost and service structure? For ...

With the UK regulatory landscape for medical devices evolving, how should a non-UK based manufacturer conduct a thorough and strategic evaluation to select a UK Responsible Person (UKRP) that ensures ...

With the upcoming UK regulatory deadlines approaching, non-UK based medical device manufacturers must appoint a UK Responsible Person (UKRP) to place devices on the Great Britain market. Simply select...

With the upcoming UK regulatory deadlines approaching, non-UK based medical device manufacturers face the critical task of appointing a UK Responsible Person (UKRP) to maintain market access in Great ...

For non-EU companies placing products on the European market, understanding the evolving role of the EU Responsible Person (RP) is critical, especially with shifting compliance deadlines. What key res...

Given that the EU Medical Device Regulation (MDR) establishes significant shared liability between a non-EU manufacturer and their Authorised Representative (AR), how should a manufacturer structure a...

When evaluating partners to act as an EU Responsible Person (RP) for cosmetic products, what are the key factors and service-level components that determine the overall scope and cost of engagement, e...

For non-EU based companies, particularly those in the medical device and technology sectors, consolidating representative services offers significant operational efficiency. With the General Data Prot...

For companies based outside the European Union, appointing a GDPR Article 27 Representative is a well-established compliance step. However, with the introduction of the EU AI Act, a new layer of compl...

Can a single provider act as both a GDPR Article 27 Representative and an Authorised Representative under the EU AI Act? For non-EU companies placing products or services on the European market, appo...

As non-EU manufacturers navigate various European Union regulations, the requirement to appoint a local representative is a common theme, seen in frameworks like the Medical Device Regulation (MDR). T...

For non-EU medical device manufacturers, establishing a presence in the European market involves navigating multiple, distinct regulatory frameworks. Beyond appointing an EU Authorized Representative ...

For non-EU medical device manufacturers, navigating the European market requires appointing an EU Authorized Representative (AR). However, the regulatory landscape is expanding beyond product-specific...

For a foreign cosmetic facility navigating the mandatory FDA registration and product listing requirements, what is a comprehensive framework for selecting a qualified U.S. Agent? Beyond the basic sta...

With the implementation of new mandatory requirements for cosmetic facility registration and product listing, foreign manufacturers must appoint a U.S. Agent to interact with the FDA. Beyond simply fu...

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), foreign cosmetic establishments must designate a U.S. Agent to serve as the primary point of contact for the FDA. As c...

As non-EU cosmetics brands navigate evolving EU regulations and approach key compliance deadlines, the selection of an EU Responsible Person (RP) extends far beyond a simple administrative requirement...

Given the significant EU cosmetic regulatory updates anticipated through 2026, how should a non-EU brand structure its selection process for a new Responsible Person (RP) to ensure they are not just a...